172 related articles for article (PubMed ID: 11585867)
1. 99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma.
Goel A; Baranowska-Kortylewicz J; Hinrichs SH; Wisecarver J; Pavlinkova G; Augustine S; Colcher D; Booth BJ; Batra SK
J Nucl Med; 2001 Oct; 42(10):1519-27. PubMed ID: 11585867
[TBL] [Abstract][Full Text] [Related]
2. Biological properties of chimeric domain-deleted anticarcinoma immunoglobulins.
Slavin-Chiorini DC; Kashmiri SV; Schlom J; Calvo B; Shu LM; Schott ME; Milenic DE; Snoy P; Carrasquillo J; Anderson K
Cancer Res; 1995 Dec; 55(23 Suppl):5957s-5967s. PubMed ID: 7493377
[TBL] [Abstract][Full Text] [Related]
3. Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody.
Pietersz GA; Patrick MR; Chester KA
J Nucl Med; 1998 Jan; 39(1):47-56. PubMed ID: 9443738
[TBL] [Abstract][Full Text] [Related]
4. Binding characteristics and tumor targeting of a covalently linked divalent CC49 single-chain antibody.
Beresford GW; Pavlinkova G; Booth BJ; Batra SK; Colcher D
Int J Cancer; 1999 Jun; 81(6):911-7. PubMed ID: 10362138
[TBL] [Abstract][Full Text] [Related]
5. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
Yokota T; Milenic DE; Whitlow M; Wood JF; Hubert SL; Schlom J
Cancer Res; 1993 Aug; 53(16):3776-83. PubMed ID: 8339291
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo comparison of binding of 99m-Tc-labeled anti-CEA MAb F33-104 with 99m-Tc-labeled anti-CEA MAb BW431/26.
Watanabe N; Oriuchi N; Sugiyama S; Kuroki M; Matsuoka Y; Tanada S; Murata H; Inoue T; Sasaki Y
Nuklearmedizin; 1999; 38(4):115-9. PubMed ID: 10392376
[TBL] [Abstract][Full Text] [Related]
7. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.
Milenic DE; Yokota T; Filpula DR; Finkelman MA; Dodd SW; Wood JF; Whitlow M; Snoy P; Schlom J
Cancer Res; 1991 Dec; 51(23 Pt 1):6363-71. PubMed ID: 1933899
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations.
Steffens MG; Oosterwijk E; Kranenborg MH; Manders JM; Debruyne FM; Corstens FH; Boerman OC
J Nucl Med; 1999 May; 40(5):829-36. PubMed ID: 10319758
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m radiolabeling using a phage-derived single-chain Fv with a C-terminal cysteine.
Verhaar MJ; Keep PA; Hawkins RE; Robson L; Casey JL; Pedley B; Boden JA; Begent RH; Chester KA
J Nucl Med; 1996 May; 37(5):868-72. PubMed ID: 8965166
[TBL] [Abstract][Full Text] [Related]
10. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.
Yokota T; Milenic DE; Whitlow M; Schlom J
Cancer Res; 1992 Jun; 52(12):3402-8. PubMed ID: 1596900
[TBL] [Abstract][Full Text] [Related]
11. Improved tumor radioimmunodetection using a single-chain Fv and gamma-interferon: potential clinical applications for radioimmunoguided surgery and gamma scanning.
Nieroda CA; Milenic DE; Carrasquillo JA; Scholm J; Greiner JW
Cancer Res; 1995 Jul; 55(13):2858-65. PubMed ID: 7796413
[TBL] [Abstract][Full Text] [Related]
12. Single-chain antibodies in pancreatic cancer.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Batra SK
Ann N Y Acad Sci; 1999 Jun; 880():263-80. PubMed ID: 10415872
[TBL] [Abstract][Full Text] [Related]
13. Technetium-99m labeling and biodistribution of anti-TAC disulfide-stabilized Fv fragment.
Yoo TM; Chang HK; Choi CW; Webber KO; Le N; Kim IS; Eckelman WC; Pastan I; Carrasquillo JA; Paik CH
J Nucl Med; 1997 Feb; 38(2):294-300. PubMed ID: 9025758
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts.
Choi CW; Lang L; Lee JT; Webber KO; Yoo TM; Chang HK; Le N; Jagoda E; Paik CH; Pastan I
Cancer Res; 1995 Nov; 55(22):5323-9. PubMed ID: 7585595
[TBL] [Abstract][Full Text] [Related]
15. Direct technetium-99m labeling of three anticancer monoclonal antibodies: stability, pharmacokinetics and imaging.
Gooden CS; Snook DE; Maraveyas A; Rowlinson-Busza G; Peters AM; Epenetos AA
J Nucl Med; 1995 May; 36(5):842-9. PubMed ID: 7738662
[TBL] [Abstract][Full Text] [Related]
16. Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.
Hu S; Shively L; Raubitschek A; Sherman M; Williams LE; Wong JY; Shively JE; Wu AM
Cancer Res; 1996 Jul; 56(13):3055-61. PubMed ID: 8674062
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct.
Pavlinkova G; Colcher D; Booth BJ; Goel A; Batra SK
Cancer Immunol Immunother; 2000 Jul; 49(4-5):267-75. PubMed ID: 10941910
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoscintigraphy using technetium-99m-labeled parental mouse and mouse-human chimeric antibodies to carcinoembryonic antigen in athymic nude mice bearing tumor.
Karube Y; Katsuno K; Takata J; Matsunaga K; Haruno M; Kuroki M; Arakawa F; Matsuoka Y; Kanda H
Nucl Med Biol; 1996 Aug; 23(6):753-9. PubMed ID: 8940717
[TBL] [Abstract][Full Text] [Related]
19. Gallium-68 chelate imaging of human colon carcinoma xenografts pretargeted with bispecific anti-CD44V6/anti-gallium chelate antibodies.
Klivényi G; Schuhmacher J; Patzelt E; Hauser H; Matys R; Moock M; Regiert T; Maier-Borst W
J Nucl Med; 1998 Oct; 39(10):1769-76. PubMed ID: 9776285
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and biodistribution of radioimmunoconjugates of anti-CD19 antibody and single-chain Fv for treatment of human B-cell malignancy.
Li Q; Hudson W; Wang D; Berven E; Uckun FM; Kersey JH
Cancer Immunol Immunother; 1998 Nov; 47(3):121-30. PubMed ID: 9829837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]